The buzz: A healthier future. On Pharma and Technology Part 1, we discussed the need for pharma to move quickly to introduce safe, cost-effective drugs that respond to cancer, Ebola, and other chronic and urgent diseases. Now we’ll explore how pharma and medical devices companies are working to surmount health market hurdles andprepare for a healthier global future. How soon can they glean life-saving insights by connecting the dots scientific, clinical, genomic, and patient therapy data? Will new collaboration networks add value to clinical trials and post-drug-launches? Are they optimistic? The experts speak. Ashish Goel, Infosys: “Change is not a destination, just as hope is not a strategy” (Rudy Giuliani). Alan S. Louie, Ph.D, IDC Health Insights: “Choose a job you love, and you will never have to work a day in your life” (Confucius). Joe Miles, SAP: “Test fast, fail fast, adjust fast” (Tom Peters). Join us for Pharma and Technology: Higher Outcomes, Lower Costs – Part 2.